Miransertib mesylate is a non-ATP competitive, selective AKT inhibitor that suppresses the PI3K/AKT pathway. This inhibition can impede tumor cell proliferation and promote apoptosis, as demonstrated in cellular assays and in vivo models of cancers like Proteus syndrome and various carcinomas.
Molecular Weight:
624.73
CAS Number:
[1817727-88-0]
Formula:
C29H32N6O6S2
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
